BNTX - Goldman likes McKesson in premarket analyst action March, 18 2020 07:53 AM BioNTech SE Osmotica Pharmaceuticals (NASDAQ:OSMT) initiated with Buy rating and $8 (74% upside) price target at SunTrust.More news on: Osmotica Pharmaceuticals plc, Epizyme, Inc., Baxter International Inc., Healthcare stocks news, Stocks on the move, , Read more ...